| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/29/2007 | US7223413 Composition of a potassium channel opener, a potassium channel agonist and an adenosine receptor agonist; heart can be better protected during arrest and recovery by using the potassium channel opener adenosine and the local anaesthetic lignocaine |
| 05/29/2007 | US7223397 Administering an agent which upregulates the expression of a cellular target; administering a dose of an immunotoxin directed against the upregulated cellular target |
| 05/29/2007 | US7223392 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics |
| 05/29/2007 | US7223388 Reoviridae virus is conjugated to a hydroxylated hydrocarbon or a polycationic polymer to reduce the clearance and immunogenicity; antiproliferative disorders |
| 05/29/2007 | CA2401718C Compositions and methods for treating hair loss using c16 - c20 aromatic tetrahydro prostaglandins |
| 05/29/2007 | CA2340052C Pharmaceutical compositions containing lipase inhibitors and chitosan |
| 05/29/2007 | CA2236998C Tissue-specific and target rna-specific ribozymes |
| 05/29/2007 | CA2214565C New cryptophycins from synthesis |
| 05/24/2007 | WO2007059209A2 Extract of dioscorea sp. and the medical uses thereof |
| 05/24/2007 | WO2007058626A1 Indazole compounds |
| 05/24/2007 | WO2007058346A1 HETEROCYCLIC COMPOUND HAVING INHIBITORY ACTIVITY ON 11-β-HYDROXYSTEROID DEHYDROGENASE TYPE I |
| 05/24/2007 | WO2007058322A1 Basic group-containing compound and use thereof |
| 05/24/2007 | WO2007058305A1 Process for production of cinnamamide derivative |
| 05/24/2007 | WO2007058105A1 Method for producing pancreas from es cell |
| 05/24/2007 | WO2007058027A1 Harmful bacterium control agent containing bacillus thuringiensis |
| 05/24/2007 | WO2007057571A2 3-acylindole derivatives the preparation and the therapeutic use thereof |
| 05/24/2007 | WO2007057219A1 Treatment of asthma and copd using triple-combination therapy |
| 05/24/2007 | WO2007037513A9 Aryl-substituted nitrogen-containing heterocyclic compound |
| 05/24/2007 | WO2007037133A9 Method for evaluation of compound capable of acting on plk3 |
| 05/24/2007 | WO2006091522A3 Methods for modulating macrophage proliferation in ocular disease using polyamine analogs |
| 05/24/2007 | US20070117843 Quinoline inhibitors of cGMP phosphodiesterase |
| 05/24/2007 | US20070117842 Polymorph of 4-[3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy]-7-methoxy-6- quinolinecarboxamide and a process for the preparation of the same |
| 05/24/2007 | US20070117790 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
| 05/24/2007 | US20070117773 Telomerase-inhibiting ENA oligonucleotide |
| 05/24/2007 | US20070117762 In particular, use of propionyl-L-carnitine in combination with one or more known useful drugs for preparing medicine for treatment of erectile dysfunction in patients suffering from diabetes mellitus, wherein patients do not respond to treatment with other useful drugs |
| 05/24/2007 | US20070117758 Treating treating angiogenic disease, e.g., cancer, by administering therapeutically effective amount of compounds of the invention, for example, {(3R, 4S, 5S, 6R)-5-Methoxy-4-[(2R, 3R)-2-methyl-3-(3-methyl-but-2-enyl)-oxiranyl]-1-oxa-spiro[2.5]oct-6-yloxycarbonylamino}-3-methyl-butyric acid methyl ester |
| 05/24/2007 | US20070117757 Polypeptide copolymer for use in treatment of multiple sclerosis; glatiramer acetate; copolymer-1 substantially free of species having a molecular weight of over 40 kilodaltons; chromatographic separation; cleaving by acid hydrolysis or enzymetic hydrolysis; isolation by dialysis or ultrafiltration, |
| 05/24/2007 | US20070117196 Transformed microorganism comprising an isolated fragment of DNA derived from coffee and integrated into the genome or plasmid of the mannase; involved in the hydrolysis of polysaccharides |
| 05/24/2007 | US20070117180 Enzyme producing plasma protein fragment having inhibitory activity to metastasis and growth of cancer and plasma protein fragment produced by fragmentation by said enzyme |
| 05/24/2007 | US20070117166 Use of ULIP proteins in the diagnosis and therapy of cancers and paraneoplastic neurological syndromes |
| 05/24/2007 | US20070117165 Detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 05/24/2007 | US20070117142 Regulation of novel human asparagine-hydroxylases |
| 05/24/2007 | US20070117098 'signalin' family of TGFbeta signal transduction proteins and uses related thereto |
| 05/24/2007 | US20070117091 Anti-candida agents for the treatment of prion diseases |
| 05/24/2007 | US20070116708 Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof |
| 05/24/2007 | US20070116694 Inhibitor of interaction of granzyme b with golgin-160 |
| 05/24/2007 | US20070116684 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
| 05/24/2007 | US20070116683 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
| 05/24/2007 | US20070116682 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
| 05/24/2007 | US20070116647 Medicinal preparation particularly for the treatment of slipped discs hernias |
| 05/24/2007 | US20070113727 Wireless microphone communication system |
| 05/24/2007 | DE60119515T2 Probiotica für verwendung als haustierfutter Probiotics for use as petfood |
| 05/24/2007 | CA2629977A1 Extract of dioscorea sp. and the medical uses thereof |
| 05/24/2007 | CA2628321A1 Treatment of asthma and copd using triple-combination therapy |
| 05/24/2007 | CA2628047A1 Process for production of cinnamide derivative |
| 05/23/2007 | EP1788390A1 Screening method |
| 05/23/2007 | EP1788092A1 Method of inhibiting postischemic reperfusion-induced cell death and cell death inhibitor |
| 05/23/2007 | EP1788085A1 A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 05/23/2007 | EP1787998A1 Antibody and utilization of the same |
| 05/23/2007 | EP1787992A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
| 05/23/2007 | EP1787991A1 PYRROLOÝ2,3-c¨PYRIDINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND USE |
| 05/23/2007 | EP1787986A1 Hydroxamic acid derivative and medicine containing the same as active ingredient |
| 05/23/2007 | EP1787984A2 Azacyclic compounds for use in the treatment of serotonin related diseases |
| 05/23/2007 | EP1787657A1 Therapeutic agent for psychoneurotic disease |
| 05/23/2007 | EP1787648A1 Medicinal composition for percutaneous perospirone administration |
| 05/23/2007 | EP1787646A2 Novel method of treatment |
| 05/23/2007 | EP1787529A2 Composition and methods using an eutomer |
| 05/23/2007 | EP1786810A1 Ligands for g-protein coupled receptors |
| 05/23/2007 | EP1786762A2 Amidine substituted aryl aniline compounds |
| 05/23/2007 | EP1786441A2 Method and means for enhanced pulmonary drug delivery |
| 05/23/2007 | EP1786437A2 Improved ghb compositions |
| 05/23/2007 | EP1786395A1 Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b and other therapeutic proteins |
| 05/23/2007 | EP1480679B1 Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative |
| 05/23/2007 | EP1416929A4 Cancer treatment with gö6976 and its related compounds |
| 05/23/2007 | EP1385548B1 Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions |
| 05/23/2007 | EP1369419B1 N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same |
| 05/23/2007 | EP1353910B1 Lactam compound |
| 05/23/2007 | EP1272454B1 Method for synthesis of n-[ (s)-1-carboxybutyl]-(s)-alanine esters and use in synthesis of perindopril |
| 05/23/2007 | EP1223959B1 Inhibition of cell motility and angiogenesis by inhibitors of the grb2 sh2-domain |
| 05/23/2007 | EP1218368B1 COMPOSITIONS AND METHODS FOR MODULATING APOPTOSIS IN CELLS OVER-EXPRESSING bcl-2 FAMILY MEMBER PROTEINS |
| 05/23/2007 | EP1181014B1 HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND METHOD |
| 05/23/2007 | EP1177157B1 A vital matter and a producing method |
| 05/23/2007 | EP1146788B1 Indomethacin amide derivatives for antiangiogenic and/or antitumorigenic use |
| 05/23/2007 | EP1097141B1 Imidazole derivatives with biphenylsulfonyl substitution, method for preparing them and their use as a drug or diagnostic agent |
| 05/23/2007 | EP1015015B1 pRb2/p130 PEPTIDE INHIBITORS OF cdk2 KINASE ACTIVITY |
| 05/23/2007 | EP0948335B1 Methods of treating or preventing cardiac arrhythmia |
| 05/23/2007 | EP0873407B1 Apo-2 ligand |
| 05/23/2007 | CN1968693A Medicine comprising combination of acetylcholine esterase inhibitor and 5-substituted 3-oxadiazolyl-1,6-naphthyridin-2(1H)-one derivative |
| 05/23/2007 | CN1968691A Composition for acceleration of alcohol metabolism or recuperation from fatigue through gluconeogenesis |
| 05/23/2007 | CN1968690A Inflammation inhibitor comprising zinc salt of acylamino acid |
| 05/23/2007 | CN1966725A Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma |
| 05/23/2007 | CN1966525A Human monoclonal antibodies to epidermal growth factor receptor (egfr) |
| 05/23/2007 | CN1966071A Application of edestin in preparation of anti-anoxia functional food |
| 05/23/2007 | CN1966070A Application of edestin in preparation of medicament |
| 05/23/2007 | CN1966017A Drink for removing summer-heat |
| 05/23/2007 | CN1966012A Chinese medicinal composition for relieving sports fatigue and improving performance and method for preparing same |
| 05/23/2007 | CN1966010A Medicament for opening orifices and tranquilizing mind for treating wind syndrome caused by excessive heat of infant |
| 05/23/2007 | CN1965994A Method for preparing oral liquid for sportsman |
| 05/23/2007 | CN1965931A Method for preparing medicament for fish |
| 05/23/2007 | CN1965915A Method for extracting bitter buckwheat flavone in high purity |
| 05/23/2007 | CN1965903A Application of fructus cannabis in preparation of health food for improving anoxia tolerance |
| 05/23/2007 | CN1965856A Heparin sodium injection liquid used for venous retention needle |
| 05/23/2007 | CN1965840A Method for preventing weight increase caused by antipsychotic |
| 05/23/2007 | CN1965832A Compound injection of idazoxani hydrochloride and preparation process thereof |
| 05/23/2007 | CN1965831A Application of yohimbine and berberine mixture in medicament preparation |
| 05/23/2007 | CN1317301C Modulation of IL-2-and IL-15-mediated T cell responses |
| 05/23/2007 | CN1317291C Oligonucleotide N3'-P5' thiophosphoramidates, their synthesis and use |
| 05/23/2007 | CN1317274C 1-phenyl-2-heteroaryl-substituted benzimdazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives |
| 05/23/2007 | CN1316990C Chinese medicinal composition, preparation method and quality control method thereof |
| 05/23/2007 | CN1316966C Otacosane alcohol extract micro-encapsulation powder and preparation method thereof |